Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects (Q42448720)

31 October 2017

title

Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects (English)

1 reference

31 October 2017

1 reference

Gillian E Walker

1

1 reference

31 October 2017

Paolo Marzullo

2

1 reference

31 October 2017

Barbara Verti

3

1 reference

31 October 2017

Gabriele Guzzaloni

4

1 reference

31 October 2017

Sabrina Maestrini

5

1 reference

31 October 2017

Francesco Zurleni

6

1 reference

31 October 2017

Antonio Liuzzi

7

1 reference

31 October 2017

Anna Maria Di Blasio

8

1 reference

31 October 2017

publication date

1 September 2008

1 reference

31 October 2017

1 reference

31 October 2017

volume

16

1 reference

31 October 2017

issue

9

1 reference

31 October 2017

page(s)

1983-1991

1 reference

A transgenic model of visceral obesity and the metabolic syndrome

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Rationale of subdermal superficial liposuction related to the anatomy of subcutaneous fat and the superficial fascial system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

The homeostasis model in the San Antonio Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

A comparison of abdominal subcutaneous adipose tissue pattern in obese and lean HIV-infected women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

In vivo human lipolytic activity in preperitoneal and subdivisions of subcutaneous abdominal adipose tissue.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Effect of troglitazone on body fat distribution in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

7 January 2021

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

7 January 2021

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

7 January 2021

Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.326

7 January 2021

Identifiers

DOI

10.1038/OBY.2008.326

1 reference

31 October 2017

1 reference